155 related articles for article (PubMed ID: 32291735)
21. NETest: A Systematic Review Focusing on the Prognostic and Predictive Role.
Puliani G; Di Vito V; Feola T; Sesti F; Centello R; Pandozzi C; Tarsitano MG; Verrico M; Lenzi A; Isidori AM; Giannetta E; Faggiano A
Neuroendocrinology; 2022; 112(6):523-536. PubMed ID: 34515175
[TBL] [Abstract][Full Text] [Related]
22. Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study.
van Treijen MJC; Korse CM; van Leeuwaarde RS; Saveur LJ; Vriens MR; Verbeek WHM; Tesselaar MET; Valk GD
Front Endocrinol (Lausanne); 2018; 9():740. PubMed ID: 30564197
[No Abstract] [Full Text] [Related]
23. Neuroendocrine Tumor Omic Gene Cluster Analysis Amplifies the Prognostic Accuracy of the NETest.
Kidd M; Kitz A; Drozdov I; Modlin I
Neuroendocrinology; 2021; 111(5):490-504. PubMed ID: 32392558
[TBL] [Abstract][Full Text] [Related]
24. Concept of reintervention with thorough lymphadenectomy after suboptimal resection of small-intestine neuroendocrine neoplasms: A multicentre preliminary study.
Deguelte S; Hammoutene C; Poncet G; Brunaud L; Perrier M; Kianmanesh R; Cadiot G
J Neuroendocrinol; 2022 Jun; 34(6):e13117. PubMed ID: 35434838
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity and Specificity of the NETest: A Validation Study.
Al-Toubah T; Cives M; Valone T; Blue K; Strosberg J
Neuroendocrinology; 2021; 111(6):580-585. PubMed ID: 32615553
[TBL] [Abstract][Full Text] [Related]
26. Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.
Bodei L; Kidd M; Modlin IM; Severi S; Drozdov I; Nicolini S; Kwekkeboom DJ; Krenning EP; Baum RP; Paganelli G
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):839-851. PubMed ID: 26596723
[TBL] [Abstract][Full Text] [Related]
27. The NETest: The Clinical Utility of Multigene Blood Analysis in the Diagnosis and Management of Neuroendocrine Tumors.
Modlin IM; Kidd M; Malczewska A; Drozdov I; Bodei L; Matar S; Chung KM
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):485-504. PubMed ID: 30098712
[TBL] [Abstract][Full Text] [Related]
28. NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance.
van Treijen MJC; Korse CM; Verbeek WH; Tesselaar MET; Valk GD
Endocr Connect; 2022 Oct; 11(10):. PubMed ID: 35951312
[TBL] [Abstract][Full Text] [Related]
29. Small Intestinal Neuroendocrine Neoplasm: Factors Associated with the Development of Local Tumor-Related Symptoms.
Deguelte S; Metoudi A; Rhaiem R; Hoeffel C; Brixi H; Cadiot G; Kianmanesh R
Neuroendocrinology; 2022; 112(3):252-262. PubMed ID: 33853084
[TBL] [Abstract][Full Text] [Related]
30. The clinical utility of circulating neuroendocrine gene transcript analysis in well-differentiated paragangliomas and pheochromocytomas.
Pęczkowska M; Cwikla J; Kidd M; Lewczuk A; Kolasinska-Ćwikła A; Niec D; Michałowska I; Prejbisz A; Januszewicz A; Chiarelli J; Bodei L; Modlin I
Eur J Endocrinol; 2017 Feb; 176(2):143-157. PubMed ID: 27913608
[TBL] [Abstract][Full Text] [Related]
31. Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.
Van Den Heede K; Chidambaram S; Van Slycke S; Brusselaers N; Warfvinge CF; Ohlsson H; Nordenström E; Almquist M
Br J Surg; 2022 Feb; 109(2):191-199. PubMed ID: 34941998
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood.
Öberg K; Califano A; Strosberg JR; Ma S; Pape U; Bodei L; Kaltsas G; Toumpanakis C; Goldenring JR; Frilling A; Paulson S
Ann Oncol; 2020 Feb; 31(2):202-212. PubMed ID: 31959337
[TBL] [Abstract][Full Text] [Related]
33. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
34. Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider?
Daskalakis K; Tsolakis AV
World J Gastroenterol; 2018 Aug; 24(29):3201-3203. PubMed ID: 30090001
[TBL] [Abstract][Full Text] [Related]
35. Role of Primary Tumor Resection for Metastatic Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):213-218. PubMed ID: 32797281
[TBL] [Abstract][Full Text] [Related]
36. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
Farley HA; Pommier RF
Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
[TBL] [Abstract][Full Text] [Related]
37. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
[TBL] [Abstract][Full Text] [Related]
39. NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis.
Malczewska A; Oberg K; Kos-Kudla B
Endocr Connect; 2021 Jan; 10(1):110-123. PubMed ID: 33289691
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
